BDBM358591 4-acetyl-1-(3-(4-amino-5- chloropyrrolo[2,1-f][1,2,4]triazin-7- yl)phenyl)-6-(hydroxymethyl)-3,3- dimethylpiperazin-2-one::US10214537, Example 668
SMILES: CC(=O)N1CC(CO)N(C(=O)C1(C)C)c1cccc(c1)-c1cc(Cl)c2c(N)ncnn12
InChI Key: InChIKey=RBRNULWGKSDUEF-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human)) | BDBM358591 (4-acetyl-1-(3-(4-amino-5- chloropyrrolo[2,1-f][1,2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company US Patent | Assay Description The ADP-Glo format PI3K assays were performed in Proxiplate 384-well plates (Perkin Elmer #6008280). The final assay volume was 2 μl prepared fr... | US Patent US10214537 (2019) BindingDB Entry DOI: 10.7270/Q2HH6NB2 | |||||||||||
More data for this Ligand-Target Pair |